Microparticles in Pediatric Inflammatory Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00979485|
Recruitment Status : Terminated (initial results suggest no significant trends will be observed with completion of study)
First Posted : September 18, 2009
Last Update Posted : June 23, 2011
|Condition or disease|
|Crohn's Disease Ulcerative Colitis|
Once the response of microparticles to inflammation is defined in this patient population, the microparticles can be used as biomarkers of disease activity and could potentially use microparticles as targets of therapeutic agents.
This cross sectional study will enroll 15 Crohn's patients (5 inactive, 5 mild, 5 moderate-severe disease based on the pediatric Crohn's disease activity index), 15 Ulcerative Colitis patients (5 inactive, 5 mild, 5 moderate-severe disease based on the pediatric ulcerative colitis activity index), and 10 healthy controls.
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Observational Model:||Case Control|
|Official Title:||Microparticles in Pediatric Inflammatory Bowel Disease|
|Study Start Date :||August 2009|
|Actual Primary Completion Date :||May 2011|
|Actual Study Completion Date :||May 2011|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00979485
|United States, Indiana|
|Indiana Unversity, Riley Hospital for Children|
|Indianapolis, Indiana, United States, 46202|
|Principal Investigator:||Steven ` Steiner, MD||Indiana University|